Merksem - HOSP ZNA Jan Palfijn

Merksem 2170

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 1

Studies at this site

• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) — Completed